Schedule 13G Filing for Bionano Genomics, Inc.

CVI Investments, Inc. and Heights Capital Management, Inc. have filed a Schedule 13G indicating beneficial ownership of 9.9% of Bionano Genomics, Inc.'s common stock. The filing details the ownership of 1,021,671 shares, which includes shares issuable upon the exercise of warrants. Heights Capital Management, Inc. serves as the investment manager for CVI Investments, Inc. and may exercise voting and dispositive power over the shares. The filing is made pursuant to Rule 13d-1(c) and includes a Limited Power of Attorney and a Joint Filing Agreement as exhibits.